Multidisciplinary management, standards of care, optimal diagnostics, therapies and future perspectives in the care of Cervical Cancer patients in sub-Saharan Africa.

Lead Faculty: Prof. Fredrick Chite Asirwa MD

Consultant Physician. Medical Oncologist & Hematologist

Executive Director/CEO: International Cancer Institute (ICI)

P.O. Box 8088, Code 30100 Eldoret, Kenya

Email: director@intercancer.com

Website: www.intercancer.com

This educational activity is provided by the International Cancer Institute (ICI)

Faculty

1. Dr. Elly Odongo-Gynecologic Oncologist
2. Dr. Dawit Worku-Gynecologic Oncologist
3. Dr. Gregory Ganda-Gynecologic Oncologist
4. Dr. Muluken Gizaw-Public Health Specialist
5. Dr. Verna Vanderpuye-Consultant Radiation Oncologist
6. Dr. Elias Hussein- Palliative care specialist/ Family Medicine
7. Dr. Mary Nyangasi-Public Health & Policy Specialist
8. Dr. Siwilis Mithe- Clinical Oncologist
9. Dr. Kibet Keitany- Anatomic Pathologist

This course will be accredited by:

Target Audience

The primary target audience for this course comprises the multidisciplinary clinical cancer care team members including, but not limited to medical, surgical, and radiation oncologists; fellows; gastroenterologists; nephrologists; neurologists; pathologists; pulmonologists; radiologists; researchers; oncology nurse practitioners and oncology nurses; Oncology pharmacists; Oncology PharmTechs; Oncology clinical officers; physician assistants; and other allied health care professionals.

Statement of Need

General internists and Primary Care Clinicians must maintain an extensive knowledge base on a wide variety of topics covering all body systems as well as common and uncommon disorders. International Cancer Institute’s Preceptorship Courses aims to leverage the expertise of its Faculty to help clinicians understand best practices in diagnosis and management of conditions encountered in the clinical setting in sub-Saharan Africa.

LEARNING OBJECTIVES

At the end of this educational activity, participants should be able to:

1. Recognize the global burden of cervical cancer and compare its incidence in more and less developed regions
2. Describe the epidemiology, etiology and methods of prevention (including role of HPV) of cervical cancer and management of pre-malignant lesions.
3. Recognize the role of pathological diagnosis and staging procedures/studies-including diagnostic and radiological procedures for cervical cancer
4. To understand the role of surgery in the management of cervical cancer
5. To understand the role of radiotherapy in the management of cervical cancer
6. Appreciate the Management of locally advanced cervical cancer
7. Appreciate the role of systemic therapies, including antiangiogenic therapy in cervical cancer treatment as part of the standard of care treatment protocols
8. Recall the goals and standard of care in the management of metastatic cervical cancer.
9. Understand the role of Palliative, supportive and survivorship care in cervical cancer management
10. To discuss clinical cases between faculty and participants

Disclosure of Conflicts of Interest

Disclosure of Conflicts of Interest International Cancer Institute (ICI) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ICI for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
The faculty must report any financial relationships or contractual relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labelled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Method of Participation and Request for Credit.

To receive credit for this activity, participants must review the activity information including learning objectives and faculty/planner disclosures and actively participate in the educational activity. Upon successfully completing the post-test with a score of 75% or better and the post-activity evaluation, your certificate will be made available immediately.

The Program

LECTURES

1. Orientation to the course (Chite) Monday 18th May 2020 4:00-4:30 PM EAT
2. Epidemiology of cervical cancer in sub-Saharan Africa vs Global burden (Muluken) Wednesday 20th May 2020 4:00-5:30 PM EAT
3. Cervical Cancer Prevention & management of pre-malignant lesions (Elly) 25th May 2020 4:00-5:30 PM EAT
4. Pathological diagnostics and pathology interpretation in cervical Cancer (Kibet) 27th May 2020 4:00-5:30 PM EAT
5. The Role of Surgery in cervical cancer management (Ganda) 1st June 2020 4:00-5:30 PM EAT
6. Staging in cervical cancer (Siwillis) 3rd June 2020 4:00-5:30 PM EAT
7. Management of Early stage cervical Cancer (Dawit) 8th June 2020 4:00-5:30 PM EAT
8. Management of locally advanced cervical cancer (Verna) 10th June 2020 4:00-5:30 PM EAT
9. Public Health perspectives in the Prevention and control of cervical cancer (Nyangasi) 15th June 2020 4:00-5:30 PM EAT
10. Management of Metastatic or Recurrent Cervical Cancer (Chite) 17th June 2020 4:00-5:30 PM EAT
11. Supportive, Palliative and Survivorship care in cervical Cancer Care (Hussein) 22nd June 2020 4:00-5:30 PM EAT
12. End of course Examination (Chite) 24th June 2020 4:00-5:30 PM EAT

Participants should be willing to spend at least 4 hours per week on this online course over a period of 6 weeks. (Duration 24 hours)

All those interested in registration to this course, please send your information to info@intercancer.com

Acknowledgements

ICI Acknowledges that the funding for this preceptorship training has been proudly supported by the Roche as part of ICI_Roche Shining Tower Project (STP).